[go: up one dir, main page]
More Web Proxy on the site http://driver.im/

van Genderen et al., 1994 - Google Patents

The reliability of Hickman catheter blood for the assessment of activation markers of coagulation and fibrinolysis in patients with hematological malignancies

van Genderen et al., 1994

Document ID
17644518660159382318
Author
van Genderen P
Gomes M
Stibbe J
Publication year
Publication venue
Thrombosis research

External Links

Snippet

We studied the reliability of Hickman catheter (HC) blood for the determination of activation markers of coagulation and fibrinolysis in 14 patients with hematological malignancies. 10 of 22 HC samples were contaminated with heparin, probably as a consequence of our …
Continue reading at www.sciencedirect.com (other versions)

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
    • G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/86—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving blood coagulating time or factors, or their receptors
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
    • G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
    • G01N33/483—Physical analysis of biological material
    • G01N33/487—Physical analysis of biological material of liquid biological material
    • G01N33/49—Blood
    • G01N33/4905—Determining clotting time of blood
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
    • G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/80—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving blood groups or blood types or red blood cells
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
    • G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES OR MICRO-ORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or micro-organisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/56—Measuring or testing processes involving enzymes, nucleic acids or micro-organisms; Compositions therefor; Processes of preparing such compositions involving blood clotting factors, e.g. involving thrombin, thromboplastin, fibrinogen

Similar Documents

Publication Publication Date Title
Millar et al. An evaluation of the heat precipitation method for plasma fibrinogen estimation
Denson et al. The measurement of heparin
Polack et al. Preanalytical recommendations of the ‘Groupe d’Etude sur l’Hemostase et la Thrombose’(GEHT) for venous blood testing in hemostasis laboratories
Bick et al. A new two-stage functional assay for antithrombin-III (heparin cofactor): clinical and laboratory evaluation
Contant et al. Heparin inactivation during blood storage: its prevention by blood collection in citric acid, theophylline, adenosine, dipyridamole-CTAD mixture
Kidder et al. The plasma protamine paracoagulation test: clinical and laboratory evaluation
WO2002079375A1 (en) Rapid assessment of coagulation activity in whole blood
Nsiri et al. Abnormalities of coagulation and fibrinolysis in homozygous sickle cell disease
JP3075751B2 (en) Inhibitors for anticoagulant pretreatment of blood samples
Epstein et al. Radioimmunoassays for protein C and factor X: Plasma antigen levels in abnormal hemostatic states
Levine et al. The effect of platelet factor 4 (PF4) on assays of plasma heparin
Osterud How to measure factor VII and factor VII activation
Collen et al. Quantitation of thrombin‐antithrombin III complexes in human blood
Carvalho et al. Activation of the coagulation system in polycythemia vera
HOLM et al. The antithrombotic effect of heparin in deep venous thrombosis: relation to four heparin assays
van Genderen et al. The reliability of Hickman catheter blood for the assessment of activation markers of coagulation and fibrinolysis in patients with hematological malignancies
Despotis et al. In Vitro reversal of Heparin Effect with Heparinas: evaluation with whole blood Prothrombin Time and activated partial Thromboplastin Time in Cardiac Surgical Patients
Nordby et al. The euglobulin clot lysis time, a rapid and sensitive method for the assay of fibrinolytic activity after venous stasis
Chen et al. One-stage assay of heparin
Andrew et al. Dysfunctional antithrombin III in sick premature infants
Hedlund et al. The effect of prophylaxis with low dose heparin on blood coagulation parameters
Singh et al. Effect of long-term use of NORPLANTR implants on haemostatic function
Leroy-Matheron et al. Influence of conditions of blood sampling on coagulation activation markers (prothrombin fragment 1+ 2, thrombin-antithrombin complexes and D-dimers) measurements
Kisker et al. The effects of combined platelet and leukapheresis on the blood coagulation system
Fekete et al. Laboratory modalities for assessing hemostasis during cardiopulmonary bypass